Announcements Trials
Browse Landscape

Phase

Phase EARLY_PHASE1 2Phase 2/3 1Phase 2 1

Status

Unknown 2Recruiting 1Completed 1

Sponsor Class

OTHER 4INDUSTRY 2

Study Type

Interventional 4

Sponsor

Conditions

Breast Neoplasms 7244Neoplasms 4539Prostatic Neoplasms 3489Colorectal Neoplasms 2940Carcinoma, Non-Small-Cell Lung 2831Lung Neoplasms 2547Leukemia, Myeloid, Acute 1982Pancreatic Neoplasms 1874Multiple Myeloma 1811Carcinoma, Hepatocellular 1733Neoplasm Metastasis 1585Stomach Neoplasms 1502Lymphoma 1457Precursor Cell Lymphoblastic Leukemia-Lymphoma 1435Head and Neck Neoplasms 1435Brain Neoplasms 1373Melanoma 1348Ovarian Neoplasms 1342Leukemia 1303Rectal Neoplasms 1270Recurrence 1255Colonic Neoplasms 1204Glioblastoma 1138Uterine Cervical Neoplasms 1096Lymphoma, Non-Hodgkin 1066Leukemia, Lymphocytic, Chronic, B-Cell 989Esophageal Neoplasms 965Lymphoma, Follicular 936Lymphoma, Large B-Cell, Diffuse 932Squamous Cell Carcinoma of Head and Neck 921

Interventions

ivosidenib 1Magnesium 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
OTHER × Interventional × AML × Clear all
NCT06717958 2025-07-02

PIVOT

Technische Universität Dresden

Phase 2 Recruiting
76 enrolled

AML

NCT03275636 2024-08-07

HAMLET

DKMS gemeinnützige GmbH

Phase 2/3 Completed
98 enrolled

AML

NCT05252572 2022-02-23

Clinical Study of CLL1 CAR-T Cells in the Treatment of Hematological Malignancies

Zhejiang University

Phase EARLY_PHASE1 Unknown
36 enrolled

AML

NCT05239689 2022-02-15

Clinical Study of CD38 CAR-T Cells in the Treatment of Hematological Malignancies

Zhejiang University

Phase EARLY_PHASE1 Unknown
36 enrolled

AML

Data powered by HemOnc (CC BY 4.0) Colophon âš¡